(Q31102883)

English

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology (English)

1 reference

Europe PubMed Central

28 June 2017

0 references

genitourinary oncology

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

William E Grizzle

1

1 reference

Europe PubMed Central

28 June 2017

O John Semmes

2

1 reference

Europe PubMed Central

28 June 2017

Joseph Basler

3

1 reference

Europe PubMed Central

28 June 2017

Elzbieta Izbicka

4

1 reference

Europe PubMed Central

28 June 2017

Ziding Feng

5

1 reference

Europe PubMed Central

28 June 2017

Jacob Kagan

6

1 reference

Europe PubMed Central

28 June 2017

Bao-Ling Adam

7

1 reference

Europe PubMed Central

28 June 2017

Dean Troyer

8

1 reference

Europe PubMed Central

28 June 2017

Sudhir Srivastava

9

1 reference

Europe PubMed Central

28 June 2017

Mark Thornquist

10

1 reference

Europe PubMed Central

28 June 2017

Zhen Zhang

11

1 reference

Europe PubMed Central

28 June 2017

Ian M Thompson

12

1 reference

Europe PubMed Central

28 June 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

28 June 2017

Urologic Oncology

1 reference

Europe PubMed Central

28 June 2017

22

1 reference

Europe PubMed Central

28 June 2017

337-343

1 reference

Europe PubMed Central

28 June 2017

4

1 reference

Europe PubMed Central

28 June 2017

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

The nature of prostate cancer detected through prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Age-specific reference ranges for serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Complexed Prostate Specific Antigen Improves Specificity for Prostate Cancer Detection: Results of a Prospective Multicenter Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Serum proteomic patterns for detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Phases of biomarker development for early detection of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Expectant management of localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenocarcinoma of the prostate: results of routine urological screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2004.04.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLONC.2004.04.008

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31102883&oldid=1962860228"